Trials / Completed
CompletedNCT04673994
Blood Flow Response and Acute INterval Exercise
Cerebrovascular Response During Interval Exercise in Chronic Stroke
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 91 (actual)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The objective of this project is to study the cerebrovascular response to a single bout of high intensity interval exercise (HIIT) in 25 individuals with chronic stroke compared to 25 age- and sex- matched healthy controls (CON). We will enroll 25 young healthy adults (CONyoung) as a reference group. Our hypothesis is that the cerebrovascular response in individuals with chronic stroke will be significantly lower: 1) during a single bout of HIIT, and 2) during the recovery immediately following and 30 minutes after HIIT, compared to CON. This study has 2 visits at the University of Kansas Medical Center Research in Exercise and Cardiovascular Health Laboratory. For the first visit, we will perform questionnaires about heart health, physical activity and overall health. Participants will then complete a submaximal exercise test on a seated stepper. Participants will also have a familiarization session to practice HIIT. The second visit will include cerebrovascular measures before, during, immediately after, and 30 minutes after performing HIIT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Single, acute bout of high intensity interval exercise | Individuals will perform a single bout of high intensity interval exercise on a seated recumbent stepper. Participants will perform the pattern of high intensity interval exercise by switching between 1-minute high intensity stepping followed by 1-minute light, active recovery stepping for a total of 10 minutes. |
Timeline
- Start date
- 2020-12-09
- Primary completion
- 2023-02-03
- Completion
- 2023-02-03
- First posted
- 2020-12-17
- Last updated
- 2023-02-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04673994. Inclusion in this directory is not an endorsement.